http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002038045-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C259-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C259-06 |
| filingDate | 2001-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b9ba5a060017358d2cbe744752bfae6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56d6f4455902809f4613c8453d0ecd7c |
| publicationDate | 2002-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2002038045-A1 |
| titleOfInvention | Hydroxamic acid derivatives |
| abstract | Novel hydroxamic acid compounds, e.g., of formula I, n n n wherein R 1 , R 2 , R 3 and R 4 are as defined, are found to be useful as pharmaceuticals, e.g., for the suppression of TNF release and the treatment of autoimmune and inflammatory diseases, e.g., multiple sclerosis and rheumatoid arthritis. Methods of making the compounds, novel intermediates, and pharmaceutical compositions comprising the compounds are provided. |
| priorityDate | 1996-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 252.